Sign In
×How did analysts view Jamjoom Pharma’s Q3 financials?Argaam Special05/12/2023
GIB Capital sets rating for Jamjoom PharmaArgaam03/12/2023
Jamjoom Pharma offers SAR 18.5M corporate guarantee for Algeria JV Argaam22/11/2023
Jamjoom Pharma board OKs 10% dividend for H1 2023ِArgaam10/08/2023
Jamjoom Pharma to raise capital of its Algeria joint ventureArgaam31/07/2023
How did analysts view Jamjoom Pharma’s Q3 financials?Argaam Special05/12/2023
GIB Capital sets rating for Jamjoom PharmaArgaam03/12/2023
Argaam Reports
How did analysts view Jamjoom Pharma’s Q3 financials?Argaam Special05/12/2023
TASI leaps 5.5% in 9M 2023; Etihad Atheeb, Elm top gainersِArgaam special 30/09/2023
Jamjoom Pharma revises up 2023 guidanceArgaam Special10/08/2023
Market Data
Last Trade | 111.80 |
Change | (2.20) |
Change (%) | (1.93) |
Open | 114.00 |
Low | 110.80 |
High | 114.20 |
Prev. Close | 114.00 |
Change (3M) | (2.27 %) |
Change (6M) | n/a |
Volume | 671,163 |
Turnover | 75,008,030.00 |
Transactions | 5,443 |
Market Value | 7,826.00 |
Avg. Volume (3M) | 310,070.55 |
Avg. Turnover (3M) | 34,477,104.73 |
Avg. Transaction (3M) | 2,614.89 |
Change(12M) | n/a |
YTD | n/a |
Event Date
|
Event
|
Venue
|
|
---|---|---|---|
07-11-2023
|
Financial results date | - | |
07-11-2023
|
Conferences | - | |
03-09-2023
|
Cash Dividend Distribution | - | |
20-08-2023
|
Ex-dividend Date | - | |
10-08-2023
|
Conferences | - | |
more |
Date | Research firm | Rating |
|
GIB Capital | Neutral |
|
Al Rajhi Capital | Overweight |
|
Al Rajhi Capital | Overweight |
|
GIB Capital | Overweight |

Call Request